Skip to content

Study · Case report or series · n = 1 · 2020

1 result

MON-365 Novel Use of Abaloparatide to Augment Spinal Fusion in Patient Undergoing Cervicothoracic Revision Surgery

Parikh S, Lubitz S, Sharma A

Journal of the Endocrine Society8 May 2020

PMCIDPMC7207413 (opens in a new tab)PepBankPUB-98679207

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanCase report or seriesEfficacy outcome

    In a woman receiving abaloparatide after revision surgery, CT showed cervicothoracic fusion without non-union at 3 and 6 months.

    In plain wordsIn one woman receiving abaloparatide after revision surgery, scans showed spinal fusion without non-union at 3 and 6 months.

    Outcome
    Not applicableCervicothoracic fusion
    Study

    n = 1

    Outcome group
    Bone and joint · Musculoskeletal
    Studied dose
    80mcg daily · planned 12-week courseAs given in this study (human).

    Source sentences

    Summary
    Cervical CT at 3 and 6 months showed post-surgical cervicothoracic fusion with no signs of non-union.
    2 context sentences
    Summary · context
    Case Presentation 66 year-old female with a history of multiple sclerosis, obesity and hypothyroidism underwent neurosurgical evaluation of neck pain.
    Summary · context
    Patient started on Abaloparatide 80mcg daily 2 weeks post procedure with planned 12-week therapy course.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.